Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 8714975, 7 pages
Research Article

Extra-Intestinal Fluoroquinolone-Resistant Escherichia coli Strains Isolated from Meat

1Department of Sciences for Health Promotion and Mother & Child Care, University of Palermo, Italy
2Institute for Experimental Veterinary Medicine of Sicily, Palermo, Italy

Correspondence should be addressed to Teresa Fasciana; ti.oiligriv@anaicsaf.aseret

Received 26 June 2018; Revised 17 September 2018; Accepted 28 October 2018; Published 18 November 2018

Guest Editor: Maria E. Potes

Copyright © 2018 Giorgia Caruso et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Extra-intestinal E. coli are emerging as a global threat due to their diffusion as opportunistic pathogens and, above all, to their wide set of antibiotic resistance determinants. There are still many gaps in our knowledge of their origin and spread pathways, although food animals have been adjudicated vehicles for passing mult-drug resistant bacteria to humans. This study analyzed 46 samples of meat purchased from retail stores in Palermo in order to obtain quinolone-resistant E. coli isolates. Strains were screened for their phylogenetic groups, ST131-associated single nucleotide polymorphisms (SNPs), and then typed by ERIC-PCR. Their set of virulence factors, namely, kpsMII, papA, sfaS, focG, iutA, papC, hlyD, and afa genes, were investigated and their fluoroquinolone-resistance determinants evaluated. The data obtained show a dramatically high prevalence of multidrug resistance patterns in the Palermo area, with 28% of the isolates having virulence factor genes typical of ExPEC strains. No B2 group or ST131 strains were detected. Moreover, 20% of our isolates showed positivity to all the plasmid-mediated quinolone resistance (PMQR) determinants, showing a potential to transfer these genes among other bacteria. Therefore, these data underline the possibility that food animals and, specifically, poultry in particular may be a significant source of resistant bacterial strains, posing a potential zoonotic risk.

1. Introduction

The outburst of the antibiotic resistance phenomenon at global level has occurred due to the excessive and inappropriate use of antimicrobials in various fields, both in human medicine and in veterinary and zootechnical settings, strongly accelerating the development and diffusion of resistant strains. For instance, intensive livestock farming practices that compel farmers to rely more heavily on antibiotics have determined a dramatic increase in the prevalence of antibiotic-resistant bacteria in farm animals and food [1, 2].

Quinolones in particular have long been the main choice of antimicrobial agent for the treatment of various Gram-negative infections, both in human and in veterinary medicine, ostensibly increasing the rate of resistant isolates all over the world [3]. Furthermore, the World Health Organization (WHO) has signalled quinolones to be critically important antibiotics, thus recommending a more prudent use of them [4]. In fact, since the discovery of the first plasmid-mediated quinolone resistance (PMQR) gene in 1998 [5], many other resistance mechanisms have been added [6].

Nontarget, commensal enteric bacteria are also exposed to this wide variety of antimicrobial substances, leading to an increase in resistance genes and, potentially, their horizontal transfer. Hence these bacteria may function as a reservoir of resistance though largely ignored [7].

According to the EFSA and ECDC report [8], E. coli is an excellent indicator of resistance level among Enterobacteria in breeding animals, as it is widespread in farm environments.

Furthermore, there is increasing evidence that E. coli strains may be conveyed through food and, directly or more likely indirectly, they find their way to humans, accounting for a subset of resistant Extra-intestinal Pathogenic E. coli (ExPEC) [911]. Indeed, ExPEC increasingly represent an emerging category of pathogens that cause illness in immunocompetent subjects both in nosocomial and in community settings. ExPEC are in fact implicated in a wide range of host diseases and are associated with the vast majority of urinary tract infections (UTIs), as well as neonatal meningitis and bacteremia and animal infective syndromes [12].

E. coli ST131 is currently the predominant isolate among ExPEC lineages at global level [13] and is considered to be one of the most virulent bacterial clones, particularly linked to fluoroquinolone-resistance (e.g., qnrA, qnrB, qnrS, and aac (6’)-Ib-cr genes) and to extended-spectrum β-lactamases, such as CTX-M-15 [14]. Moreover, ST131 isolates are commonly reported to harbour a wide variety of virulence-associated genes, including a greater ability to produce biofilms compared to non-ST131 isolates [15]. Due to these features, ST131 strains are considered to be truly pathogenic [13]. The aim of this study, therefore, was to assess the prevalence of multidrug resistant E. coli with ExPEC-associated traits in food that could pose a risk for consumers.

2. Materials and Methods

2.1. Strain Selection

Between January and March 2017, 46 samples were analyzed at the Experimental Zooprophylactic Institute of Sicily “A. Mirri.” All the samples, in individually sealed packages, were purchased from different supermarkets in Palermo. They consisted of 23 poultry, 13 beef and 10 pork samples. According to the labels, all the samples came from intensive farms based in Sicily.

The samples were immediately sent to the laboratory on ice and subsequently processed in asepsis.

10 g of each sample was added to 90 ml of saline peptone solution (SSP). After homogenization by Stomacher and incubation for one hour at room temperature, samples were plated into Tryptone Bile X-Glucuronide (TBX) Agar. Colonies developed 18 to 24 hours after incubation at 44°C. They were tested by disk diffusion for resistance to fluoroquinolones, in particular to ciprofloxacin (CIP, 5 μg), norfloxacin (NOR, 10 μg), and levofloxacin (LVX, 5 μg) (Oxoid). A resistant colony was selected from each sample and then identified by the API E (BioMérieux) system.

A single colony was suspended in 200 μl sterile bidistilled water. DNA extraction was then performed by High Pure PCR Template Preparation Kit (Roche), according to the manufacturer’s instructions.

2.2. Phylogenetic Grouping

DNA extracts were analysed with multiplex PCR to ascertain their phylogenetic groups, as described by Clermont et al. [16]. This method is based on the presence/absence of three genes: chuA, which encodes a protein transporting the eme group, yjaA, with an unknown function, and the fragment TSPE4.C2, thought to be within a gene encoding a lipase esterase. Previously studied strains from our laboratory were used as positive controls [17].

2.3. Virulence Factors

Two multiplex PCRs were assayed to investigate the presence of eight virulence factors (VFs) in the E. coli isolates, as described by Johnson et al. [18]. The first multiplex PCR screened for the presence of kpsMII (group II capsule), papA (pilus-associated protein A), sfaS (S-fimbrial adhesine), and focG (F1C fimbriae protein) genes; the second one searched for hlyD (haemolysin D), afa (afimbrial adhesine), iutA (aerobactin siderophore ferric receptor protein), and papC (pilus-associated protein C) genes. Positive results for at least two of these VFs are a distinctive sign of ExPEC [18]. Three strains were employed as positive controls: E. coli RS218 (kpsMT II, papA, papC, sfaS, and hlyD), E. coli V27 (kpsMT II, papA, papC, iutA, and focG), and E. coli 2H16 (papC, iutA, afa, and hlyD) [17].

2.4. Genotypic Detection of Plasmid Resistance Genes

Strain genotypes were investigated with relation to the most common plasmid-mediated quinolone resistance genes: qnrA, qnrB, qnrS, and aac(6’)-Ib-cr [19, 20].

2.5. Typing

All the strains were typed in order to screen for ST131-associated single nucleotide polymorphisms (SNPs) in mdh and gyrB, according to Johnson et al. [21]. Hence a multiplex PCR was carried out, and the presence of the two amplicons relating to the two abovementioned genes qualified the strain as ST131.

They were then subjected to Enterobacterial Repetitive Intergenic Consensus sequence PCR (ERIC-PCR), according to Versalovic et al. [22].

The fingerprints were photographed by the GelDoc (BIO-RAD) system and finally analyzed using the BIO-NUMERICS software (Applied Maths, Kortrijk, Belgium). Comparisons between band patterns were performed with the Dice similarity coefficient. The obtained matrices were combined using the UPGMA algorithm to produce a dendrogram, with a cut-off of 80% similarity.

2.6. Antibiotic Testing

Besides fluoroquinolones, all the strains were tested by disk diffusion for susceptibility to other antimicrobials, including amoxicillin–clavulanic acid (AUG, 20–10 μg), cefotaxime (CTX, 30 μg), ceftazidime (CAZ, 30 μg), cefepime (PEP, 30 μg), gentamicin (CN, 10 μg), imipenem (IMI, 10 μg), sulfamethoxazole–trimethoprim (SXT, 25 μg), and tetracycline (TE, 30 μg) (Oxoid). Resistance was determined according to European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines ( Isolates simultaneously resistant to three or more different drug classes were defined as multidrug resistant (MDR) [23].

3. Results

This study analysed 46 samples. Almost all the strains isolated from poultry samples were resistant to fluoroquinolones (91.3%). A considerably lower percentage of the strains isolated from pigs and cattle showed resistance, namely, 20% and 15.3%, respectively. In total, we obtained 25 fluoroquinolone-resistant strains, to be further characterized in the following analyses.

As regards phylogenetic groups, D1 was the most prevalent (44%), followed by group A1 (28%), A0 (20%), and lastly B1 (8%); notably, no B2 group strains were observed (Figure 1).

Figure 1: Percentage of strains by phylogenetic group.

In accordance with the absence of group B2 strains, ST131 was absent among our isolates, which all tested negative for the SNPs in the two genes of interest.

A limited number of virulence factors were observed, and these were concentrated in phylogenetic group D1. In fact, this group included all the strains with the kpsMII gene and the majority with iutA gene. PapA was found in one strain, belonging to group A1.

Therefore, 7 of the 25 isolates (28%) met the inclusion criteria for ExPEC; that is, they had at least two virulence factors, according to Johnson et al. [18]. Eight isolates had one virulence determinant (Figure 2).

Figure 2: Percentages of strains possessing VFs.

The genes aac(6’)-Ib-cr, qnrA, qnrB, and qnrS encoding quinolone resistance were observed in only 20% of our isolates. In particular, both qnrA and aac(6')- Ib-cr genes appeared in 2 strains, while qnrB and qnrS were present in 1 strain each. 4 of these resistance determinants were found in group A and one in group D1; specifically, only one was found in pork meat (i.e., qnrB), while the other determinants were found in strains originating from poultry.

Phenotypic resistance patterns are summarized in Table 1. Among the 25 isolated E. coli strains, notably 80% were found to be resistant to amoxicillin–clavulanic acid. A high prevalence was found for tetracyclin and sulfamethoxazole–trimethoprim also, both present in 72% of samples. Interestingly, none of the strains were observed to be resistant to the cephalosporins and carbapenem tested. The most common pattern was resistance to amoxicillin–clavulanic acid, tetracyclin, and sulfamethoxazole–trimethoprim, which was detected in 14 of the 25 strains (56%). Hence, 19 strains (76%) can be considered multidrug resistant, according to the criterion utilized [24].

Table 1: Resistance patterns observed in all the strains.

Finally, ERIC PCR showed quite a high level of heterogeneity, except for two pairs of strains (2 pork strains and 2 poultry strains), which shared the same patterns of bands and hence are displayed only once (Figure 3).

Figure 3: Dendrogram obtained by ERIC-PCR of strains.

4. Discussion

The steady increase in the prevalence of quinolone-resistant ExPEC isolates is particularly alarming due to their spread as opportunistic pathogens and suggests the need to deepen our knowledge of their source, reservoirs, and transmission pathways.

Poultry meat was highly contaminated with E. coli resistant to quinolones (91.3% of samples). The percentage of contaminated pork and beef samples was lower, in agreement with the literature, according to which not only does the poultry show the highest quinolone resistance in comparison to other types of meat but also the highest prevalence of MDR [2527]. Lower resistance levels for beef, whose resistant strains accounted for 15.3% in this study, have also been observed in other investigations from different parts of Europe [28, 29].

The most common antibiotic classes used in bred chickens are penicillins, tetracyclines, sulfonamides and quinolones [6]. Accordingly, in our study, the highest resistance prevalence was found for amoxicillin-clavulanic acid, sulfamethoxazole–trimethoprim, and tetracycline. Carbapenems are restricted to human use, but they were investigated in this study, as required by 2013/652/EU [30], since small resistance spots are, albeit slowly, starting to emerge [31], above all in poultry, where a small percentage of carbapenemase-producing E. coli were detected from broilers and its meat in two European countries.

Although veterinary use of cephalosporins is permitted by law, notably our strains did not exhibit resistance to them. While the poultry industry in Italy renounced the use of III and IV generation cephalosporins in 2009, the other farming industries continue to use these antimicrobials for a rather wide range of diseases. Their consumption of this antibiotic class is one of the highest in Europe and has shown a slightly increasing trend since 2010 [32]. Our findings relating to cephalosporins reflect other data in the literature. Wasyl et al. [33] and Alvarez-Fernandez et al. [25] reported a very low incidence of resistance to these antibiotics (0-3.8%), and Pavlickova et al. [11] did not describe any strain as resistant to cefotaxime and cefuroxime. In contrast, another study from Sicily, but based on Italian meat, found a high prevalence of cephalosporin resistance in its strains [17].

We found a higher prevalence of phylogenetic group D1 strains (44%), followed by A1 (28%), A0 (20%), and lastly B1 (8%); these latter groups (A and B1) are usually associated with environmental and commensal strains in humans [34], while the phylogenetic groups B2 and to a lesser extent D are related to extra-intestinal pathogenic strains. Furthermore, in this study we found no evidence in the analyzed foods of an animal ST131 reservoir, in accordance with observations by other authors who only sporadically detected ST131 in farm animals [35, 36]. In fact, although other sources have been identified as ST131 vehicles, a greater prevalence of human compared to animal colonization has been observed [37].

Our isolates did not show a wide variety of VFs, as mainly the iutA receptor, present in 15 strains out of 25 (60%), and, to a lesser extent, kpsMII, present in 6 strains (24%), were found; papA gene was found in just 1 isolate. The presence of virulence genes in these strains is worrisome because it suggests a high probability of pathogenicity, according to Johnson et al.’s [18] ExPEC definition. VFs, therefore, greatly increase the health threat these strains already pose as carriers of antibiotic-resistance genes through the food chain. Specifically, 28% of isolates possessed two virulence factors (i.e., ExPEC). Lyhs et al. [38] classified 22% of strains as ExPEC in a study focused on poultry meat sold at retail stores, while Xia et al. [39] observed an even lower percentage (20.2%) in the same sample type.

However, Johnson et al.’s above-mentioned classification for determining the pathogenicity of microorganisms may not be exhaustive, as there may be other unexamined factors conferring pathogenic potential. For instance, in a study by Fasciana et al. [40], many UPEC strains, all isolated from pathological urine samples, did not exhibit any of the VFs indicated by Johnson et al. [18]. Hence it is highly likely that the number of ExPECs among farm animals has been underestimated.

As regards antibiotic resistance, since all the isolates in question exhibited phenotypic resistance to quinolones, other resistance mechanisms may explain the rather low prevalence of the PMQR genes investigated (20%). Indeed, as the most common mechanisms in animal isolates are chromosomal mutations in type II topoisomerase (parC and/or gyrA genes) [4143], or in regulatory proteins (e.g., MarA, SoxRS, and Rob) associated with upregulation of efflux pumps, such as AcrAB-TolC, and downregulation of porin, reducing quinolone influx [44], we assume that these mechanisms were responsible for resistance in our study as well. In addition, other potentially involved resistance determinants, though less frequent, are due to plasmid-encoded qepA and oqxAB membrane transporters [45, 46].

Genotyping by ERIC-PCR revealed 23 banding profiles; these results support a high genetic heterogeneity, which is an alarming fact, showing a multiple onset of MDR strains despite the restricted area of sampling.

This study, although numerically limited, emphasizes the already clear need to improve strategies to prevent the spread of antibiotic resistance and to reduce the amount of antibiotics used.

The high prevalence of resistant strains in this study, despite not all of them being classified as ExPEC, poses a direct risk, as these strains can subclinically colonize the consumer’s intestinal tract until advantageous circumstances favour an extraintestinal infection, or an indirect risk, potentially contributing resistance genes to human indigenous microbiota [47].

For instance, a subset of human ExPEC strains, isolated by Fasciana et al. [40] from UTIs in Palermo, turned out to be non-ST-131 (33%) and were not resistant to cephalosporins (32.4%). Furthermore, the most prevalent VFs observed included KpsMII (32%) and iutA (83.8%), which were reported to be more common in non-ST131 strains. These data are limited and do not allow epidemiological considerations, but they do underline, albeit partially, that it is not possible to exclude a zoonotic origin for at least a small subset of human ExPEC infections.

Given the considerable public health threat that ExPEC represents, further long-term investigations are needed to give us more insight into the epidemiologic relationship between human and food-origin E. coli, and to clarify capacity for interspecies transfer.

With regard to animal production systems, a review of farm management is essential, especially as far as intensive farming is concerned, combining good practices and applying good hygiene measures and animal welfare in order to reduce the use of antimicrobials (i.e., an efficient antimicrobial stewardship), thus acting on reservoirs of antibiotic resistance. At present, intensive farming systems rely on a routine use of antibiotics, creating reservoirs of antimicrobial resistance genes that could spread in the environment or to different hosts. In fact, antibiotics are often used as prophylactic prevention measures, for mass treatment that is not associated with a specific diagnosis or for preventable diseases, in a way that is no longer sustainable. In order to deal with this antimicrobial resistance emergency, different levels of safety measures must be considered, including “tertiary prevention” (i.e., increasing the ability of the animals’ immune system to respond to infections) [48] and vaccines formed on widely conserved antigens [49, 50].

In addition, according to the farm-to-fork concept, it is important that also slaughterhouses and food handling practices are taken into account in the attempt to reduce foodborne transmission. Hence, an integrated implementation of GMP (Good Manufacturing Practices) and GHP (Good Hygienic Practices) should be applied throughout the production, processing, and consumption stages, and consumer awareness should be raised.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

The authors declare that they have no conflicts of interest.


  1. J. Campos, J. Mourão, N. Pestana, L. Peixe, C. Novais, and P. Antunes, “Microbiological quality of ready-to-eat salads: an underestimated vehicle of bacteria and clinically relevant antibiotic resistance genes,” International Journal of Food Microbiology, vol. 166, no. 3, pp. 464–470, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. V. Perreten, “Resistance in the food chain and in bacteria from animals: relevance to human infections,” in Frontiers in Antimicrobial Resistance: A Tribute to Stuart B. Levy, D. G. White, M. N. Alekshun, and P. F. McDermott, Eds., pp. 446–464, ASM Press, Washington, DC, USA, 2005. View at Publisher · View at Google Scholar
  3. V. T. Andriole, “The quinolones: past, present, and future,” Clinical Infectious Diseases, vol. 41, supplement 2, pp. S113–S119, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. World Health Organization, WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR). Critically important antimicrobials for human medicine 3rd Revision 2011, WHO Document Production Services, Geneva, Switzerland, 2012.
  5. L. Martínez-Martínez, A. Pascual, and G. A. Jacoby, “Quinolone resistance from a transferable plasmid,” The Lancet, vol. 351, no. 9105, pp. 797–799, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. G. A. Jacoby, J. Strahilevitz, and D. C. Hooper, “Plasmid-mediated quinolone resistance,” Microbiology Spectrum, vol. 2, no. 5, Article ID PLAS-0006-2013, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. R. L. Finley, P. Collignon, D. G. J. Larsson et al., “The scourge of antibiotic resistance: the important role of the environment,” Clinical Infectious Diseases, vol. 57, no. 5, pp. 704–710, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. European Food Safety Authority and European Centre for Disease Prevention and Control, “The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2014,” EFSA Journal, vol. 14, no. 2, p. 4380, 2016. View at Google Scholar
  9. L. M. Cavaco, N. Frimodt-Møller, H. Hasman, L. Guardabassi, L. Nielsen, and F. M. Aarestrup, “Prevalence of quinolone resistance mechanisms and associations to minimum inhibitory concentrations in quinolone-resistant Escherichia coli isolated from humans and swine in Denmark,” Microbial Drug Resistance, vol. 14, no. 2, pp. 163–169, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. J. R. Johnson, M. R. Sannes, C. Croy et al., “Antimicrobial drug-resistant Escherichia coli from humans and poultry products, Minnesota and Wisconsin, 2002–2004,” Emerging Infectious Diseases, vol. 13, no. 6, pp. 838–846, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Pavlickova, M. Dolezalova, and I. Holko, “Resistance and virulence factors of Escherichia coli isolated from chicken,” Journal of Environmental Science and Health, Part B: Pesticides, Food Contaminants, and Agricultural Wastes, vol. 50, no. 6, pp. 417–421, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. J. R. Johnson and T. A. Russo, “Extraintestinal pathogenic Escherichia coli: ‘The other bad E coli’,” The Journal of Laboratory and Clinical Medicine, vol. 139, no. 3, pp. 155–162, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. M.-H. Nicolas-Chanoine, X. Bertrand, and J.-Y. Madec, “Escherichia coli ST131, an intriguing clonal group,” Clinical Microbiology Reviews, vol. 27, no. 3, pp. 543–574, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Banerjee and J. R. Johnson, “A new clone sweeps clean: The enigmatic emergence of Escherichia coli sequence type 131,” Antimicrobial Agents and Chemotherapy, vol. 58, no. 9, pp. 4997–5004, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Kudinha, J. R. Johnson, S. D. Andrew, F. Kong, P. Anderson, and G. L. Gilbert, “Escherichia coli sequence type 131 as a prominent cause of antibiotic resistance among urinary Escherichia coli isolates from reproductive-age women,” Journal of Clinical Microbiology, vol. 51, no. 10, pp. 3270–3276, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. O. Clermont, S. Bonacorsi, and E. Bingen, “Rapid and simple determination of the Escherichia coli phylogenetic group,” Applied and Environmental Microbiology, vol. 66, no. 10, pp. 4555–4558, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Ghodousi, C. Bonura, A. M. D. Noto, and C. Mammina, “Extended-spectrum β-lactamase, AmpC-producing, and fluoroquinolone-resistant Escherichia coli in retail broiler chicken meat, Italy,” Foodborne Pathogens and Disease, vol. 12, no. 7, pp. 619–625, 2015. View at Publisher · View at Google Scholar
  18. J. R. Johnson, M. A. Kuskowski, K. Smith, T. T. O'Bryan, and S. Tatini, “Antimicrobial-resistant and extraintestinal pathogenic Escherichia coli in retail foods,” The Journal of Infectious Diseases, vol. 191, no. 7, pp. 1040–1049, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. C. H. Park, A. Robicsek, G. A. Jacoby, D. Sahm, and D. C. Hooper, “Prevalence in the United States of aac(6)-Ib-cr encoding a ciprofloxacin-modifying enzyme,” Antimicrobial Agents and Chemotherapy, vol. 50, no. 11, pp. 3953–3955, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Robicsek, J. Strahilevitz, D. F. Sahm, G. A. Jacoby, and D. C. Hooper, “qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States,” Antimicrobial Agents and Chemotherapy, vol. 50, no. 8, pp. 2872–2874, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. J. R. Johnson, B. Johnston, C. Clabots, M. A. Kuskowski, and M. Castanheira, “Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States,” Clinical Infectious Diseases, vol. 51, no. 3, pp. 286–294, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Versalovic, T. Koeuth, and J. R. Lupski, “Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes,” Nucleic Acids Research, vol. 19, no. 24, pp. 6823–6831, 1991. View at Publisher · View at Google Scholar · View at Scopus
  23. A.-P. Magiorakos, A. Srinivasan, R. B. Carey et al., “Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance,” Clinical Microbiology and Infection, vol. 18, no. 3, pp. 268–281, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Exner, S. Bhattacharya, B. Christiansen, J. Gebel, P. Goroncy-Bermes, and P. Hartemann, “Antibiotic resistance: What is so special about multidrug-resistant Gram-negative bacteria?” GMS Hygiene and Infection Control, p. 12, 2017. View at Publisher · View at Google Scholar
  25. E. Álvarez-Fernández, A. Cancelo, C. Díaz-Vega, R. Capita, and C. Alonso-Calleja, “Antimicrobial resistance in E. coli isolates from conventionally and organically reared poultry: A comparison of agar disc diffusion and Sensi Test Gram-negative methods,” Food Control, vol. 30, no. 1, pp. 227–234, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Skočková, I. Koláčková, K. Bogdanovičová, and R. Karpíšková, “Characteristic and antimicrobial resistance in Escherichia coli from retail meats purchased in the Czech Republic,” Food Control, vol. 47, pp. 401–406, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. T. R. Thorsteinsdottir, G. Haraldsson, V. Fridriksdottir, K. G. Kristinsson, and E. Gunnarsson, “Prevalence and genetic relatedness of antimicrobial-resistant escherichia coli isolated from animals, foods and humans in Iceland,” Zoonoses and Public Health, vol. 57, no. 3, pp. 189–196, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. “European Food Safety Authority. Scientific opinion on the public health risks of bacterial strains producing extended-spectrum beta-lactamases and/or AmpC beta-lactamases in food producing animals,” EFSA Journals, vol. 9, p. 2322, 2011.
  29. A. Kaesbohrer, A. Schroeter, B.-A. Tenhagen, K. Alt, B. Guerra, and B. Appel, “Emerging antimicrobial resistance in commensal escherichia coli with public health relevance,” Zoonoses and Public Health, vol. 59, no. 2, pp. 158–165, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. “Commission Implementing Decision of 12 November 2013 on the monitoring and reporting of antimicrobial resistance in zoonotic and commensal bacteria,” 652, EU, 2013.
  31. “Scientific Report of EFSA and ECDC (2018) The European Union Summary Report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2016,”
  32. European Medicines Agency, “European Surveillance of Veterinary Antimicrobial Consumption (2017) Sales of veterinary antimicrobial agents in 29 European countries in 2015,”
  33. D. Wasyl, A. Hoszowski, M. Zając, and K. Szulowski, “Antimicrobial resistance in commensal Escherichia coli isolated from animals at slaughter,” Frontiers in Microbiology, vol. 4, 2013. View at Publisher · View at Google Scholar
  34. J. R. Johnson, P. Delavari, M. Kuskowski, and A. L. Stell, “Phylogenetic distribution of extraintestinal virulence-associated traits in Escherichia coli,” The Journal of Infectious Diseases, vol. 183, no. 1, pp. 78–88, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Giufrè, C. Graziani, M. Accogli, I. Luzzi, L. Busani, and M. Cerquetti, “Escherichia coli of human and avian origin: Detection of clonal groups associated with fluoroquinolone and multidrug resistance in Italy,” Journal of Antimicrobial Chemotherapy, vol. 67, no. 4, Article ID dkr565, pp. 860–867, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Vincent, P. Boerlin, D. Daignault et al., “Food reservoir for Escherichia coli causing urinary tract infections,” Emerging Infectious Diseases, vol. 16, no. 1, pp. 88–95, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. B. A. Rogers, H. E. Sidjabat, and D. L. Paterson, “Escherichia coli O25b-ST131: A pandemic, multiresistant, community-associated strain,” Journal of Antimicrobial Chemotherapy, vol. 66, no. 1, pp. 1–14, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. U. Lyhs, I. Ikonen, T. Pohjanvirta, K. Raninen, P. Perko-Mäkelä, and S. Pelkonen, “Extraintestinal pathogenic Escherichia coli in poultry meat products on the Finnish retail market.,” Acta Veterinaria Scandinavica, vol. 54, p. 64, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. X. Xia, J. Meng, S. Zhao et al., “Identification and antimicrobial resistance of extraintestinal pathogenic Escherichia coli from retail meats,” Journal of Food Protection, vol. 74, no. 1, pp. 38–44, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Fasciana, G. Giordano, P. Di Carlo et al., “Virulence factors and antimicrobial resistance of escherichia coli ST131 in community-onset healthcare-associated infections in sicily, Italy,” Pharmacologyonline, vol. 1, pp. 12–21, 2017. View at Google Scholar · View at Scopus
  41. L.-N. Xia, L. Li, C.-M. Wu et al., “A survey of plasmid-mediated fluoroquinolone resistance genes from escherichia coli isolates and their dissemination in Shandong, China,” Foodborne Pathogens and Disease, vol. 7, no. 2, pp. 207–215, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Karczmarczyk, M. Martins, T. Quinn, N. Leonard, and S. Fanning, “Mechanisms of fluoroquinolone resistance in Escherichia coli Isolates from food-producing animals,” Applied and Environmental Microbiology, vol. 77, no. 20, pp. 7113–7120, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Jones-Dias, V. Manageiro, A. P. Francisco et al., “Assessing the molecular basis of transferable quinolone resistance in Escherichia coli and Salmonella spp. from food-producing animals and food products,” Veterinary Microbiology, vol. 167, no. 3-4, pp. 523–531, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. D. C. Hooper and G. A. Jacoby, “Mechanisms of drug resistance: quinolone resistance,” Annals of the New York Academy of Sciences, vol. 1354, no. 1, pp. 12–31, 2015. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Yamane, J.-I. Wachino, S. Suzuki et al., “New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate,” Antimicrobial Agents and Chemotherapy, vol. 51, no. 9, pp. 3354–3360, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. L. H. Hansen, E. Johannesen, M. Burmølle, A. H. Sørensen, and S. J. Sørensen, “Plasmid-encoded multidrug efflux pump conferring resistance to olaquindox in Escherichia coli,” Antimicrobial Agents and Chemotherapy, vol. 48, no. 9, pp. 3332–3337, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. L. Jakobsen, D. J. Spangholm, K. Pedersen et al., “Broiler chickens, broiler chicken meat, pigs and pork as sources of ExPEC related virulence genes and resistance in Escherichia coli isolates from community-dwelling humans and UTI patients,” International Journal of Food Microbiology, vol. 142, no. 1-2, pp. 264–272, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. N. C. Maldonado, C. S. de Ruiz, M. C. Otero, F. Sesma, and M. E. Nader-Macías, “Lactic acid bacteria isolated from young calves - Characterization and potential as probiotics,” Research in Veterinary Science, vol. 92, no. 2, pp. 342–349, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Wieser, E. Romann, G. Magistro et al., “A multiepitope subunit vaccine conveys protection against extraintestinal pathogenic Escherichia coli in mice,” Infection and Immunity, vol. 78, no. 8, pp. 3432–3442, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. U. Dobrindt and J. Hacker, “Targeting virulence traits: potential strategies to combat extraintestinal pathogenic E. coli infections,” Current Opinion in Microbiology, vol. 11, no. 5, pp. 409–413, 2008. View at Publisher · View at Google Scholar · View at Scopus